Loading...
Loading...
Teva Pharmaceutical Industries Ltd.
TEVA announced today that its
Board of Directors has agreed with Dr. Jeremy Levin that he will step
down as President and Chief Executive Officer. The Board has named Eyal
Desheh, Teva's Executive Vice President and Chief Financial Officer, to
fill the role of President and Chief Executive Officer on an interim
basis, effective immediately, and it has formed a committee that will
promptly begin to search for a permanent successor.
Dr. Phillip Frost, Chairman of the Board, stated “On behalf of the
entire Board of Directors, I would like to thank Dr. Jeremy Levin for
his meaningful contribution to Teva during the last two years. The Board
and management team are fully committed to the implementation
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in